AzTrials
AzTrials

Total Joint ArthroplastyNCT05399186

Arthroplasty and Modifiable Risk Factors

A study testing Early preoperative assessment and optimization in people with Total Joint Arthroplasty and Risk Reduction, run by Landspitali University Hospital at 1 site in Iceland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hip and knee total joint arthroplasty are one of the most frequently performed surgery worldwide. However, prosthetic joint infection remains a devastating complication of them, associated with severe morbidity, increased mortality and huge costs. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Early preoperative assessment and optimization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,484 participants
Where
1 siteIceland
Study dates
20 Aug 2018to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All adult patients undergoing elective primary arthroplasty of either hip or knee at Landspitali University Hospital

Who cannot join

  • Contraindications for operation detected after inclusion. Patients having an operation on another joint within the inclusion period were not re-included.

Trial locations and contacts

1 site in 1 country.

Iceland1 site
  • Landspitali University Hsopital

    Reykjavik, Hringbraut, 108

Other trials in Iceland

About this study

Official title: Incidence of Modifiable Risk Factors and Their Association With Infections in Primary Elective Arthroplastic Surgery

Hip and knee total joint arthroplasty are one of the most frequently performed surgery worldwide. However, prosthetic joint infection remains a devastating complication of them, associated with severe morbidity, increased mortality and huge costs. Several underlying medical conditions that have been identified as independent risk factors for development of prosthetic joint infection.

The hypothesis of the study is that by utilizing the waiting time for operation (6 -12 months) to improve the state of known modifiable risk factors the frequency of prosthetic joint infection may be decreased. This optimization was established with co-operation between hospital and primary care.

Read more

Therefore a prospective non-randomized quality control study before and after an intervention regarding preoperative preparation for total joint arthroplasty of either hip or knee was planned.

The control arm was included one week prior to surgery at the anesthesia preoperative assessment outpatient clinic and were operated on between 27/8 2018 and 7/9 2020 and consists of 738 patients.

Inclusion of the interventional arm happened at the orthopedic outpatient clinic from 2/1 2019 - 30/1 2021, 6 -12 months prior to surgery and an appointment with their general physician ensured within 3 weeks for further evaluation. Enlisted have been 1010 patients, operation of them started 25/3 2019 and to date 710 patients have been operated on, but due to delays caused by Covid-19 (SARS-CoV-2) surgery of them is still ongoing.

The effect of the intervention will be evaluated with by comparison of patient characteristics and frequency of surgical site and prosthetic joint infections before and after.

Read the detailed description

Hip and knee total joint arthroplasty allow effective treatment of disability and pain due to joint destruction, and are one of the most frequently performed surgery worldwide. Surgical-site infections remain a serious complication of total joint arthroplasty, occurring in 1-7% of cases. The most severe form of surgical site infection, prosthetic joint infection is a devastating complication associated with severe morbidity, increased mortality and huge costs. There are several underlying medical conditions that have been identified as independent risk factors for development of prosthetic joint infection that might be improved before operation, called modifiable risk factors, namely pre-operative anemia, obesity, diabetes, poor nutritional status, smoking and physical activity.

The hypothesis of the study is that by utilizing the waiting time for operation (6 -12 months) to improve the state of known modifiable risk factors the frequency of prosthetic joint infection may be decreased. This optimization was established with co-operation between hospital and primary care.

Therefore a prospective non-randomized quality control study before and after an intervention regarding preoperative preparation for total joint arthroplasty of either hip or knee, comparing patient characteristics and outcome was planned.

Control Arm: Inclusion of 'usual care' patients started 20/8 2018 one week prior to surgery at the anesthesia preoperative assessment outpatient clinic. At that point in time there were 561 patients already on a waiting list for either hip or knee arthroplastic surgery. The next four months to 31/12 2018 66 more patients were added to the study. After 1/1 2019 (when collection to the interventional part had started) further 111 patients were added (15% of the 'usual care' group). These were patients where it had been missed to offer or had declined participation in the interventional arm of the study at the orthopedic outpatient clinic and when discovered at the preoperative clinic one week prior to surgery were offered participation in the 'usual care' arm as they had received traditional preoperative preparation. Operation of these patients started at 27/8 2018 and lasted to 7/9 2020 and consists of total of 738 individuals.

Interventional arm: Inclusion into the interventional arm of the study occurred between 2/1 2019 to 30/1 2021, 6 -12 months prior to surgery at the orthopedic outpatient clinic, ensuring an appointment with the patient general physician within 3 weeks afterwards to further analyze results of blood test and assess if further tests, treatments or consultation of other specialists would be preferred to optimize their condition. Patients at extremes of BMI also had a nutritional advice at the hospital. Enlisted have been 1010 patients, operation of them started 25/3 2019 and to date 710 patients have been operated on, but due to delays caused by COVID-19 (SARS-CoV-2) surgery of them is still ongoing.

Outcome variables: Information was gathered regarding age, gender, smoking, comorbidities, type of surgery, type of anesthesia, ASA classification, weight, physical activity, laboratory values (Hb, Glu, HbA1c, Albumin. Lymphocytes, D-vitamin), blood transfusions and length of stay. Postoperative follow up happened first 3 weeks postoperatively at primary care for suture removal and then 6 weeks at the outpatient orthopedic clinic. Notes from these visits were studied to identify surgical site complications, including surgical site infection, prosthetic joint infection, surgical site drainage, bleeding, dehiscence, and hematoma and evaluated according to CDC's National Healthcare Safety Network and PJI diagnosis. Also, a two year follow will occur by analysis of patient journal in regards of complications of the arthroplasty.

Statistical methods. Patient demographics will be described as median (interquartile range) for continuous variables, and number (percentage) for categorical variables. Mean and standard deviation (SD) will be reported for normally distributed data. A univariate association between the presence of modifiable risk factors and the presence of postoperative surgical site infection will be assessed using chi-squared test for categorical variables and t-test for continuous variables. As this is a descriptive study and incidence of modifiable risk factors not known in the cohort no assessment of power was performed prior to analysis. To study if there is a difference between the groups a t-test or non-parametric Wilcoxon rank sum test or Hotelling's t will be used for continuous parameters, and chi-squared test or Fisher's exact test to compare categorical parameters. Poisson regression or negative binominal regression of zero inflated regression will be used to study if a difference in the frequency of complications has occurred after the intervention. These methods might be subjected to change if unexpected factors arise during analysis of data.

Being tested
Early preoperative assessment and optimization
Medical subject headings
Risk Reduction Behavior, Surgical Wound Infection, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early preoperative assessment and optimizationOther

    The interventional group received early preoperative assessment and optimization (6-12 months) prior to total joint arthroplastic surgery in cooperation between hospital and primary care

Study groups in NCT05399186
Study groupRoleWhat they receive
Control groupNo interventionUsual care group - receiving traditional preoperative preparation and assessment (1 week) prior to total joint arthroplastic surgery
Early preoperative assessment and optimizationExperimentalInterventional group - receiving early preoperative assessment and optimization (6-12 months) in wait of total joint arthroplastic surgery
Receives: Other: Early preoperative assessment and optimization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants with Surgical site infection

    Evaluated according to CDC's National Healthcare Safety Network

    Measured: 6 weeks postoperatively

  2. Number of Participants with Surgical site infection

    Evaluated according to CDC's National Healthcare Safety Network

    Measured: 2 years postoperatively

  3. Number of Participants with Prosthetic joint infection

    Evaluated according to CDC's National Healthcare Safety Network

    Measured: 6 weeks postoperatively

  4. Number of Participants with Prosthetic joint infection

    Evaluated according to CDC's National Healthcare Safety Network

    Measured: 2 years postoperatively

Secondary outcomes (9)
  1. Preoperative anemia according to WHO's definition

    Hemoglobin in blood - Preoperative anemia was defined according to WHO's definition as a haemoglobin concentration of <120 g/l and < 130 g/l in women and men, respectively, and divided into mild (110 - 120/130 g/L per gender), moderate (80-109 g/L) and severe (<80 g/L).

    Measured: At inclusion, 1 week prior to and one day after surgery

  2. Control of diabetes

    HbA1c level - Patients were considered to have diabetes if they had received this diagnosis preoperatively or had a HbA1c level >47 mmol/mol. Non-diabetic patients were considered to have dysglycemia if HbA1c was 42 - 47 mmol/mol and undiagnosed diabetes if HbA1c >47mmol/mol.

    Measured: At inclusion, 1 week prior to and one day after surgery

  3. Indication of poor glucose control

    Serum Glucose level

    Measured: At inclusion, 1 week prior to and one day after surgery

  4. Nutritional status

    S- albumin - Patients with <35g/L (3.5 g/dL) were considered to be at risk of malnutrition

    Measured: At inclusion, 1 week prior to and one day after surgery

  5. Nutritional status

    Lymphocyte count - Patients with <1,5 x 10E9/L 32 were considered to be at risk of malnutrition

    Measured: At inclusion, 1 week prior to and one day after surgery

  6. Nutritional status

    D-Vitamin - Patients with 25OHD concentration < 50 nmol/L were defined as having a deficiency

    Measured: At inclusion, 1 week prior to and one day after surgery

  7. Smoking

    Information of smoking habits were acquired through a questionnaire and divided into those that had quit smoking more than a year ago >than 6 months ago, >6 weeks ago, less than 6 weeks ago and current smokers

    Measured: At inclusion, 1 week prior to surgery

  8. Physical activity

    Information of amount of weekly physical activity was acquired through a questionnaire and divided into two classes, zero to two times per week and three to five times per week. Each occasion was graded from 1 to more than 60 minutes.

    Measured: At inclusion, 1 week prior to surgery

  9. Other postoperative complications

    Information from health records

    Measured: up to two years postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2022
  2. Study start20 Aug 2018
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Factorial
Model description
A prospective non-randomized quality control study before and after an intervention regarding preoperative preparation for total joint arthroplasty
Masking
None (open label)
Enrolment
1,484 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05399186
Sponsor's protocol ID
20220508
Status last verified
Oct 2023
First submitted
19 May 2022
Last updated
4 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Upon reasonable request

Publications

  • Sigurdardottir M, Sigurdsson MI 1,2, Vias RD, Olafsson Y, Gunnarsdottir I, Sigurdsson EL, Karason S. Long-term follow-up of surgical complications and general health after preoperative optimisation for primary arthroplasty: a prospective quasi-experimental study. BMJ Open. 2026 Aug 6;16(8):e109472. doi: 10.1136/bmjopen-2025-109472.

    PubMed 42562582

Questions about this trial

What is this clinical trial studying?

A study testing Early preoperative assessment and optimization in people with Total Joint Arthroplasty and Risk Reduction, run by Landspitali University Hospital at 1 site in Iceland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iceland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants with Surgical site infection (time frame: 6 weeks postoperatively). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05399186, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in